Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | PLAT | P00750 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31267954 | 0.96 | F2 (0.33) | F2PLATPRSS1 | |
| SCHEMBL14250714 | 0.96 | F2 (0.33) | F2PLATPRSS1 | |
| SCHEMBL14250711 | 0.96 | F2 (0.33) | F2PLATPRSS1 | |
| SCHEMBL15543154 | 0.86 | F2 (0.41) | F2PLATPRSS1 | |
| SCHEMBL4928308 | 0.72 | CA12 (0.39) | F2PLATPRSS1 | |
| SCHEMBL3838902 | 0.71 | MAP3K14 (0.31) | — | |
| SCHEMBL650795 | 0.69 | CTSD (0.39) | — | |
| SCHEMBL23975525 | 0.68 | CRBN (0.47) | — | |
| SCHEMBL4973748 | 0.68 | CRBN (0.47) | — | |
| SCHEMBL24827100 | 0.68 | CRBN (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963485-B2 | Cycloheptapeptide agents for treatment of cancer and obesity diseases | HONG KONG BAPTIST UNIVERSITY (HK) | 2018-05-08 | — | — | US | disclosed |
| US-9963485-B2 | Cycloheptapeptide agents for treatment of cancer and obesity diseases | HONG KONG BAPTIST UNIVERSITY (HK) | 2018-05-08 | — | — | US | disclosed |
| WO-2018068757-A1 | CYCLOHEPTAPEPTIDE AGENTS FOR TREATMENT OF CANCER AND OBESITY DISEASES | HONG KONG BAPTIST UNIVERSITY (CN) | 2018-04-19 | — | — | WO | disclosed |
| US-20170096454-A1 | CYCLOHEPTAPEPTIDE AGENTS FOR TREATMENT OF CANCER AND OBESITY DISEASES | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-04-06 | — | — | US | disclosed |
| US-20170096454-A1 | CYCLOHEPTAPEPTIDE AGENTS FOR TREATMENT OF CANCER AND OBESITY DISEASES | HONG KONG BAPTIST UNIVERSITY (HK) | 2017-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096454-A1 | CYCLOHEPTAPEPTIDE AGENTS FOR TREATMENT OF CANCER AND OBESITY DISEASES | VIP, PGC, GLP1R | F2 4248/4885PLAT 1904/4885PRSS1 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.